Determining Depression Treatment Preferences of Low-Income Latinos in Primary Care Settings
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00260169|
Recruitment Status : Completed
First Posted : December 1, 2005
Last Update Posted : December 10, 2013
|Condition or disease||Intervention/treatment||Phase|
|Depression||Behavioral: Collaborative care treatment Behavioral: Enhanced usual care||Not Applicable|
Depression is a serious illness that is difficult to diagnose and treat, especially in populations that underutilize mental health services. The Latino population is one such group. Accommodating patient preferences for care, provider capacities, and administrator priorities is essential to the development of effective depression care interventions that are sustainable in public sector systems. However, little is understood regarding the depression treatment preferences of low-income Latinos who have not received quality depression care and who may not feel that they can voice their opinions about their health care. In addition, little is known about the preferences, capabilities, and priorities of providers and administrators in primary care clinics. This study will determine ways to make depression care more responsive to the needs of consumers in primary care clinics serving low-income Latinos. The study will also evaluate the effectiveness of various treatments in reducing depression.
Following baseline assessments of depression treatment preferences and resources, participants in this open label study will be randomly assigned to receive collaborative care either immediately or after a waiting period. Individuals assigned to receive immediate care will undergo treatment for 12 weeks. Other participants will receive treatment at a later time. All participants will have the option to receive one of the following treatments: (1) medication management from the Depression Care Specialist (DCS) and antidepressant medication from their primary care provider (PCP); (2) cognitive-behavioral therapy from the DCS; or (3) a combination of both treatments. Depression treatment outcomes and preferences will be measured post-intervention. Provider and administrator preferences will also be measured post-intervention and potential strategies for implementing patient-centered depression care programs will be identified.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||432 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Patient-Centered Depression Care in the Public Sector|
|Study Start Date :||November 2005|
|Actual Primary Completion Date :||October 2007|
|Actual Study Completion Date :||January 2009|
Participants will receive collaborative care
Behavioral: Collaborative care treatment
Patients receiving collaborative care treatment choose 12 weeks of CBT and/or medication management (antidepressants prescribed by patients' primary care provider) from the study depression care specialist (DCS).
Active Comparator: 2
Participants will receive enhanced usual care
Behavioral: Enhanced usual care
Usual care participants are assigned to a 16-week wait-list for the study treatment, during which they are free to receive treatment elsewhere. A letter is given to participants' primary care providers (PCP) that indicates they screened positive for depression. In addition, patients receive an information booklet about depression and a community resource list.
- Depression treatment preferences as measured by a conjoint analysis survey and qualitative interviews [ Time Frame: Measured at Week 16 ]
- Depression outcomes as measured by the Patient Health Questionnaire-9 [ Time Frame: Measured at Week 16 ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00260169
|United States, California|
|H. Claude Hudson Comprehensive Health Center|
|Los Angeles, California, United States, 90007|
|USC Family Practice Center at California Hospital|
|Los Angeles, California, United States, 90015|
|LAC+USC Outpatient Department|
|Los Angeles, California, United States, 90033|
|Principal Investigator:||Isabel T. Lagomasino, MD, MSHS||University of Southern California|
|Principal Investigator:||Megan Dwight-Johnson, MD, MPH||VA Medical Center-West Los Angeles|